Laboratory indicators and liver transplantation characteristics
Analysis of preoperative laboratory indicators (Table 2), including blood tests (WBC, HBG, NE, PLT), liver and kidney functions (ALT, AST, TBIL, DBIL, ALB, AKP, γ-GGT, BUN, CREA), blood glucose (GLU), coagulation function (PT, INR), and blood lipids (TG, CHOL) between the PTLD group and the control group revealed that there were statistically significant differences in postoperative platelets, ALT, AST, CHOL and serum tacrolimus concentration (P<0.05). The patient was administered tacrolimus (anti-rejection treatment plan) after liver transplantation; therefore, their serum tacrolimus concentrations were continuously monitored. Statistical analysis revealed that the average serum tacrolimus concentrations of patients in the PTLD and control groups were 8.28±1.61 ng/mL and 7.32±1.63ng/mL, respectively, postoperative. Similarly, a statistically significant difference was observed between the serum tacrolimus concentrations of the PTLD and control groups (P<0.05) (Table 2).
As shown in Table 2, graft weight, graft body weight ratio, transplant type, intraoperative blood loss, and blood type were not related to the occurrence of PTLD.